Literature DB >> 29440182

Shedding Light on IDH1 Mutation in Gliomas.

Todd C Hollon1, Daniel A Orringer2.   

Abstract

IDH mutation is of central importance in the diagnosis and treatment of gliomas. Fourier-transform infrared spectroscopy, in combination with a supervised machine-learning approach, can be used to detect metabolic alterations induced by IDH1 mutations in a fraction of the time of conventional techniques. Clin Cancer Res; 24(11); 2467-9. ©2018 AACRSee related article by Uckermann et al., p. 2530. ©2018 American Association for Cancer Research.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29440182      PMCID： PMC5984674          DOI： 10.1158/1078-0432.CCR-18-0011

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


  5 in total

1.  Intraoperative mass spectrometry mapping of an onco-metabolite to guide brain tumor surgery.

Authors:  Sandro Santagata; Livia S Eberlin; Isaiah Norton; David Calligaris; Daniel R Feldman; Jennifer L Ide; Xiaohui Liu; Joshua S Wiley; Matthew L Vestal; Shakti H Ramkissoon; Daniel A Orringer; Kristen K Gill; Ian F Dunn; Dora Dias-Santagata; Keith L Ligon; Ferenc A Jolesz; Alexandra J Golby; R Graham Cooks; Nathalie Y R Agar
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-30       Impact factor: 11.205

2.  The Role of Extent of Resection in IDH1 Wild-Type or Mutant Low-Grade Gliomas.

Authors:  Toral Patel; Evan D Bander; Rachael A Venn; Tiffany Powell; Gustav Young-Min Cederquist; Peter M Schaefer; Luis A Puchi; Akbarshakh Akhmerov; Shahiba Ogilvie; Anne S Reiner; Nelson Moussazadeh; Viviane Tabar
Journal:  Neurosurgery       Date:  2018-06-01       Impact factor: 4.654

3.  Rapid Intraoperative Molecular Characterization of Glioma.

Authors:  Ganesh M Shankar; Joshua M Francis; Mikael L Rinne; Shakti H Ramkissoon; Franklin W Huang; Andrew S Venteicher; Elliot H Akama-Garren; Yun Jee Kang; Nina Lelic; James C Kim; Loreal E Brown; Sarah K Charbonneau; Alexandra J Golby; Chandra Sekhar Pedamallu; Mai P Hoang; Ryan J Sullivan; Andrew D Cherniack; Levi A Garraway; Anat Stemmer-Rachamimov; David A Reardon; Patrick Y Wen; Priscilla K Brastianos; William T Curry; Fred G Barker; William C Hahn; Brian V Nahed; Keith L Ligon; David N Louis; Daniel P Cahill; Matthew Meyerson
Journal:  JAMA Oncol       Date:  2015-08       Impact factor: 31.777

4.  IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection.

Authors:  Jason Beiko; Dima Suki; Kenneth R Hess; Benjamin D Fox; Vincent Cheung; Matthew Cabral; Nicole Shonka; Mark R Gilbert; Raymond Sawaya; Sujit S Prabhu; Jeffrey Weinberg; Frederick F Lang; Kenneth D Aldape; Erik P Sulman; Ganesh Rao; Ian E McCutcheon; Daniel P Cahill
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

5.  Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome.

Authors:  Zachary J Reitman; Genglin Jin; Edward D Karoly; Ivan Spasojevic; Jian Yang; Kenneth W Kinzler; Yiping He; Darell D Bigner; Bert Vogelstein; Hai Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-02       Impact factor: 12.779
  5 in total
  3 in total

1.  Rapid Automated Analysis of Skull Base Tumor Specimens Using Intraoperative Optical Imaging and Artificial Intelligence.

Authors:  Cheng Jiang; Abhishek Bhattacharya; Joseph R Linzey; Rushikesh S Joshi; Sung Jik Cha; Sudharsan Srinivasan; Daniel Alber; Akhil Kondepudi; Esteban Urias; Balaji Pandian; Wajd N Al-Holou; Stephen E Sullivan; B Gregory Thompson; Jason A Heth; Christian W Freudiger; Siri Sahib S Khalsa; Donato R Pacione; John G Golfinos; Sandra Camelo-Piragua; Daniel A Orringer; Honglak Lee; Todd C Hollon
Journal:  Neurosurgery       Date:  2022-03-30       Impact factor: 5.315

Review 2.  Bridging Cancer Biology with the Clinic: Comprehending and Exploiting IDH Gene Mutations in Gliomas.

Authors:  Ourania Romanidou; Vassiliki Kotoula; George Fountzilas
Journal:  Cancer Genomics Proteomics       Date:  2018 Sep-Oct       Impact factor: 3.395

Review 3.  Label-free brain tumor imaging using Raman-based methods.

Authors:  Todd Hollon; Daniel A Orringer
Journal:  J Neurooncol       Date:  2021-02-21       Impact factor: 4.506
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.